MDT

88.69

-0.03%↓

VEEV

282.61

+1.3%↑

A

120.6

-0.78%↓

WBA

11.54

+0.26%↑

HQY

98.77

-3.58%↓

MDT

88.69

-0.03%↓

VEEV

282.61

+1.3%↑

A

120.6

-0.78%↓

WBA

11.54

+0.26%↑

HQY

98.77

-3.58%↓

MDT

88.69

-0.03%↓

VEEV

282.61

+1.3%↑

A

120.6

-0.78%↓

WBA

11.54

+0.26%↑

HQY

98.77

-3.58%↓

MDT

88.69

-0.03%↓

VEEV

282.61

+1.3%↑

A

120.6

-0.78%↓

WBA

11.54

+0.26%↑

HQY

98.77

-3.58%↓

MDT

88.69

-0.03%↓

VEEV

282.61

+1.3%↑

A

120.6

-0.78%↓

WBA

11.54

+0.26%↑

HQY

98.77

-3.58%↓

Search

Pacific Biosciences of California Inc

Ouvert

SecteurSoins de santé

1.42 -4.05

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.41

Max

1.49

Chiffres clés

By Trading Economics

Revenu

-428M

-426M

Ventes

-2.1M

37M

Marge bénéficiaire

-1,146.812

Employés

575

EBITDA

-420M

-403M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+46.94% upside

Dividendes

By Dow Jones

Prochains Résultats

6 août 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

141M

480M

Ouverture précédente

5.47

Clôture précédente

1.42

Sentiment de l'Actualité

By Acuity

50%

50%

162 / 376 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Bullish Evidence

Pacific Biosciences of California Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

8 juil. 2025, 19:37 UTC

Principaux Mouvements du Marché
Acquisitions, Fusions, Rachats

M3-Brigade Shares Fall on Merger With ReserveOne

8 juil. 2025, 23:45 UTC

Market Talk

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8 juil. 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

8 juil. 2025, 23:27 UTC

Market Talk

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8 juil. 2025, 23:27 UTC

Market Talk

Global Equities Roundup: Market Talk

8 juil. 2025, 23:21 UTC

Market Talk

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8 juil. 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8 juil. 2025, 22:29 UTC

Acquisitions, Fusions, Rachats

Capricorn to Pay A$1.5 Million in Cash and Shares

8 juil. 2025, 22:28 UTC

Acquisitions, Fusions, Rachats

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8 juil. 2025, 21:58 UTC

Market Talk

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8 juil. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8 juil. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 juil. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8 juil. 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 juil. 2025, 19:53 UTC

Market Talk

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8 juil. 2025, 19:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8 juil. 2025, 19:45 UTC

Market Talk

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8 juil. 2025, 19:29 UTC

Market Talk

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8 juil. 2025, 19:20 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

8 juil. 2025, 19:11 UTC

Market Talk

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8 juil. 2025, 19:01 UTC

Market Talk

Oil Futures Gain With Support From Products -- Market Talk

8 juil. 2025, 18:49 UTC

Résultats

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8 juil. 2025, 18:41 UTC

Market Talk

Mexico's Inflation Seen Mixed in June -- Market Talk

8 juil. 2025, 18:38 UTC

Market Talk

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8 juil. 2025, 18:23 UTC

Market Talk

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8 juil. 2025, 18:10 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8 juil. 2025, 18:10 UTC

Market Talk

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8 juil. 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8 juil. 2025, 17:06 UTC

Market Talk

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8 juil. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Comparaison

Variation de prix

Pacific Biosciences of California Inc prévision

Objectif de Prix

By TipRanks

46.94% hausse

Prévisions sur 12 Mois

Moyen 2.16 USD  46.94%

Haut 3 USD

Bas 1.25 USD

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

8 ratings

5

Achat

3

Maintien

0

Vente

Score Technique

By Trading Central

1.13 / N/ASupport & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

162 / 376Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Pacific Biosciences of California Inc

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.